glp-1 news employers Some US to drop coverage of obesity drugs in 2027 as use increases Key Employer Considerations for GLP-1

M., & Gooren, L

Fractional absorption of L-carnitine after oral administration in rats: evaluation of absorption site and dose dependency

Current evidence regarding toxicity from GHK-Cu is limited, but factors such as product concentration, frequency of use, and underlying health conditions (like Wilson's disease) may influence risk considerations

Rosenblatt, R.F

Clinical trials conducted on Wegovy patients revealed that approximately 44 percent reported nausea, while almost 25 percent reported vomiting, both of which are common symptoms of gastroparesis

Many patients on GLP-1s may report feeling less inclined to drink alcohol, which could be due to direct GLP-1 pathways in the brain